Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Lento Bio logo — Restoring Tissue Flexibility and Function in Chronic Disease...

Lento Bio

Restoring Tissue Flexibility and Function in Chronic Diseases of Aging

Founded 2022 United States Syracuse, United States 1 employees Biotechnology, Pharmaceutical

General Information

Company Name Lento Bio
Founded Year 2022
Location United States Syracuse, United States
Employees 1
Industries Biotechnology, Pharmaceutical
Social

BounceWatch is an independent company data service, not affiliated with Lento Bio. To contact Lento Bio, visit lentobio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Lento Bio

Lento Bio is a biotechnology and pharmaceutical startup founded in 2022 with the slogan "Restoring Tissue Flexibility and Function in Chronic Diseases of Aging." The company's focus is on developing effective, safe, and durable treatments for chronic age-related diseases. It was formed in partnership with Ichor Life Sciences, leveraging their expertise to directly target molecular damage using small molecules. Lento Bio's headquarters is located in the United States. As of now, details regarding the last investment and the involved investors are not available. However, with its promising mission and strategic partnership, Lento Bio presents itself as an intriguing prospect for potential venture capital investment. The innovative approach to address age-related diseases through molecular targeting aligns with the growing demand for advancements in the biotechnology and pharmaceutical industries. As the startup continues to progress in its research and development efforts, it may attract substantial attention from venture capital firms seeking investment opportunities in groundbreaking healthcare solutions.

Taxonomy: Biochemistry, Aging, Chronic diseases, Small molecule therapeutics, Medical research, Age-related disease, Molecular damage, Advanced Glycation End Products (AGEs), Presbyopia, Molecular targeting, Drug development, Bioscience, Medical technology, Innovation

No funding data available for Lento Bio yet.

Lento Bio Alternatives & Competitors

Lento Bio vs
Cognition Therapeutics, Inc.
Cognition Therapeutics, Inc. United States

Advancing Accessible Solutions for Complex Neurodegenerative Diseases

IPO
29 employees
Biotechnology, Health Care
Lento Bio vs
Revel Pharmaceuticals
Revel Pharmaceuticals United States

Revel Pharmaceuticals is a biotechnology commercializing therapeutic enzymes to degrade age associat...

Seed
7 employees
Biotechnology, Life Sciences
Lento Bio vs
Sirtris Pharmaceuticals
Sirtris Pharmaceuticals

Developing innovative, orally available small molecule drugs to combat aging-related diseases like T...

Debt Financing
Biotechnology, Health Care

FAQ About Lento Bio

Restoring Tissue Flexibility and Function in Chronic Diseases of Aging
Lento Bio was founded in 2022.
Lento Bio is headquartered in Syracuse, United States.
Lento Bio operates in Biotechnology and Pharmaceutical. Its work centres on Biochemistry, Aging, Chronic diseases and Small molecule therapeutics.
Lento Bio has approximately 1 employees.
Top alternatives and competitors to Lento Bio include Cognition Therapeutics, Inc., Revel Pharmaceuticals, Sirtris Pharmaceuticals, ALSP, Inc., DNX Biopharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Lento Bio and Cognition Therapeutics, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Lento Bio, https://bouncewatch.com/company/lento-bio, updated 11 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes